Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Cardiologists make history with HF treatment | Mild COVID-19 & heart damage | More from TCT 2021
Monday, November 8, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Ohio State cardiologists first in US to perform new heart failure treatment—patient feels ‘100% better’

The procedure, performed as part of a clinical trial, appears to have been a complete success. 

READ MORE >
Cardiologist heart
Share on Twitter Share on Facebook Share on Linkedin

Ohio State cardiologists first in US to perform new heart failure treatment—patient feels ‘100% better’

Share on Twitter Share on Facebook Share on Linkedin
Cardiologist heart
The procedure, performed as part of a clinical trial, appears to have been a complete success. 
READ MORE >

Mild COVID-19 infections not associated with long-term risk of heart damage

The new study, published in JACC: Cardiovascular Imaging, suggests that asymptomatic individuals do not need to be screened after recovering from a mild COVID-19 diagnosis.

READ MORE >
Patient doctor with masks
Share on Twitter Share on Facebook Share on Linkedin

Mild COVID-19 infections not associated with long-term risk of heart damage

Share on Twitter Share on Facebook Share on Linkedin
Patient doctor with masks
The new study, published in JACC: Cardiovascular Imaging, suggests that asymptomatic individuals do not need to be screened after recovering from a mild COVID-19 diagnosis.
READ MORE >

5 years later, TAVR still delivering strong results for intermediate-risk patients

Researchers presented their findings at TCT 2021, noting that TAVR and surgery had similar mortality rates after five years. 

READ MORE >
Old doctor
Share on Twitter Share on Facebook Share on Linkedin

5 years later, TAVR still delivering strong results for intermediate-risk patients

Share on Twitter Share on Facebook Share on Linkedin
Old doctor
Researchers presented their findings at TCT 2021, noting that TAVR and surgery had similar mortality rates after five years. 
READ MORE >

TAVR more cost-effective than surgery for low-risk patients, new 2-year study confirms

The analysis, presented at TCT 2021, examined total costs after two years for more than 900 patients who underwent TAVR or SAVR.

READ MORE >
heart.png
Share on Twitter Share on Facebook Share on Linkedin

TAVR more cost-effective than surgery for low-risk patients, new 2-year study confirms

Share on Twitter Share on Facebook Share on Linkedin
heart.png
The analysis, presented at TCT 2021, examined total costs after two years for more than 900 patients who underwent TAVR or SAVR.
READ MORE >

Icosapent ethyl lowers risk of ischemic events in CABG patients

Researchers examined data from CABG patients who participated in the REDUCE-IT trial. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Icosapent ethyl lowers risk of ischemic events in CABG patients

Share on Twitter Share on Facebook Share on Linkedin
Researchers examined data from CABG patients who participated in the REDUCE-IT trial. 
READ MORE >

Featured Articles

CMS finalizes COVID-19 vaccine mandate for healthcare workers, requiring full vaccination by Jan. 4

The policy covers all healthcare providers that participate in Medicare or Medicaid. 

READ MORE >
Vaccination
Share on Twitter Share on Facebook Share on Linkedin

CMS finalizes COVID-19 vaccine mandate for healthcare workers, requiring full vaccination by Jan. 4

Share on Twitter Share on Facebook Share on Linkedin
Vaccination
The policy covers all healthcare providers that participate in Medicare or Medicaid. 
READ MORE >

The Biden administration just made it easier to repair medical devices—and imaging specialists are concerned

The "right to repair" debate moves forward with a move that MITA has described as "misguided." 

READ MORE >
PresidentBiden.jpg
Share on Twitter Share on Facebook Share on Linkedin

The Biden administration just made it easier to repair medical devices—and imaging specialists are concerned

Share on Twitter Share on Facebook Share on Linkedin
PresidentBiden.jpg
The "right to repair" debate moves forward with a move that MITA has described as "misguided." 
READ MORE >

CABG still the ‘treatment of choice’ for patients with complex three-vessel CAD

The findings were presented at TCT 2021 and published in the New England Journal of Medicine.

READ MORE >
elderly patient mask covid
Share on Twitter Share on Facebook Share on Linkedin

CABG still the ‘treatment of choice’ for patients with complex three-vessel CAD

Share on Twitter Share on Facebook Share on Linkedin
elderly patient mask covid
The findings were presented at TCT 2021 and published in the New England Journal of Medicine.
READ MORE >

Sacubitril/valsartan no better than valsartan alone for advanced heart failure

"Every clinical outcome that we measured favored treatment with valsartan alone," one researcher said. 

READ MORE >
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Share on Twitter Share on Facebook Share on Linkedin

Sacubitril/valsartan no better than valsartan alone for advanced heart failure

Share on Twitter Share on Facebook Share on Linkedin
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
"Every clinical outcome that we measured favored treatment with valsartan alone," one researcher said. 
READ MORE >

Patients amenable to interventional procedure for lowering blood pressure

The analysis, presented at TCT 2021, included input from 400 patients with high blood pressure. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Patients amenable to interventional procedure for lowering blood pressure

Share on Twitter Share on Facebook Share on Linkedin
The analysis, presented at TCT 2021, included input from 400 patients with high blood pressure. 
READ MORE >

In Other News

Star New York Mets pitcher says MRI positioning aggravated forearm strain

Four-time All-Star Jacob deGrom spent 60 minutes on his stomach with elbow raised above his head and believes the awkward angle aggravated his injury. 

READ MORE >
baseball
Share on Twitter Share on Facebook Share on Linkedin

Star New York Mets pitcher says MRI positioning aggravated forearm strain

Share on Twitter Share on Facebook Share on Linkedin
baseball
Four-time All-Star Jacob deGrom spent 60 minutes on his stomach with elbow raised above his head and believes the awkward angle aggravated his injury. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme